Research Article Open Access Introduction Cerebral small vessel disease (SVD) is a disease of the smallest blood vessels in the brain and associated with increased risk of dementia and stroke.1 Features of SVD are commonly seen in elderly individuals on MRI), including white matter hyperintensities (WMH), lacunes, and cerebral microbleeds.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by H. Bea
Altered brain expression and cerebrospinal fluid levels of TIMP4 in cerebral amyloid angiopathy - Acta Neuropathologica Communications
Human post-mortem formalin-fixed and paraffin-embedded (FFPE) occipital lobe tissue was obtained from Radboudumc Nijmegen, the Netherlands Brain bank (NBB; Amsterdam), the University Medical center Utrecht (UMCU), and the NeuroBiobank of the Institute Born-Bunge (NBB-IBB; Wilrijk (Antwerp), Belgium).
Proximity extension assay in cerebrospinal fluid identifies neurofilament light chain as biomarker of neurodegeneration in sporadic cerebral amyloid angiopathy | Alzheimer's Research & Therapy | Full Text
sCAA patients (n = 44) were included at the Radboud University Medical Center (RUMC) in Nijmegen, the Netherlands. Most of the sCAA patients (n = 42) were enrolled through cross-sectional cohort studies (Cerebral Amyloid Angiopathy Vascular Imaging and fluid markers of Amyloid deposition (CAVIA), BIOmarkers for cogNitive Impairment due to Cerebral amyloid angiopathy (BIONIC), aimed at identifying new CSF biomarkers for sCAA at the RUMC (Website: www.radboudumc.nl/BCS) [9,10,11,12,13].
The relation of a cerebrospinal fluid profile associated with Alzheimer’s disease with cognitive function and neuropsychiatric symptoms in sporadic cerebral amyloid angiopathy | Alzheimer's Research & Therapy | Full Text
We included participants from two studies, which were largely comparable in study procedures, allowing for pooling of data. Patients with sCAA were from the BIONIC (BIOmarkers for cogNitive Impairment due to Cerebral amyloid angiopathy; www.radboudumc.nl/BCS) and the FOCAS (Follow-up in sporadic CAA Study) studies. The BIONIC study is a cross-sectional cohort study on CSF biomarkers for sCAA situated in the Radboud University Medical Center (RUMC), Nijmegen.
Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients - Acta Neuropathologica Communications
The rTg-DI rat model expresses human APP with K670N/M671L Swedish and CAA E693Q/D694N Dutch/Iowa mutations, under control of the neuronal-specific Thy1.2 promoter [16]. Non-transgenic littermates were included as wild-type controls (WT). rTg-DI and WT rats were sampled for CSF from the cisterna magna at 3 M, 6 M, and 12 M of age. For this, the rats were anaesthetized using isoflurane inhalation.
Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy - Alzheimer's Research & Therapy
The main findings of our study were as follows: (1) In patients with symptomatic D-CAA, levels of plasma Aβ42 were significantly decreased, as consistently established in two independent cohorts. (2) Plasma levels of Aβ38, Aβ40, and Aβ42 were not consistently decreased in patients with presymptomatic D-CAA, and Aβ40 and Aβ42 were not consistently decreased in patients with symptomatic D-CAA, across two independent cohorts.
Decreased ratios of matrix metalloproteinases to tissue-type inhibitors in cerebrospinal fluid in sporadic and hereditary cerebral amyloid angiopathy
Alzheimer's Research & Therapy, Jan 2023 This is a preview of a remote PDF: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-023-01171-3 Vervuurt, Marc, de Kort, Anna M., Jäkel, Lieke, Kersten, Iris, Abdo, Wilson F., Schreuder, Floris H. B. M., Rasing, Ingeborg, Terwindt, Gisela M., Wermer, Marieke J. H., Greenberg, Steven M., Klijn, Catharina J. M., Kuiperij, H. Bea, Verbeek, Marcel M.. , Alzheimer's Research & Therapy, 2023, pp. 1-14, Volume 15, Issue 1, DOI: 10.1186/s13195-023-01171-3
Decreased ratios of matrix metalloproteinases to tissue-type inhibitors in cerebrospinal fluid in sporadic and hereditary cerebral amyloid angiopathy - Alzheimer's Research & Therapy
References Jäkel L, De Kort AM, Klijn CJM, Schreuder F, Verbeek MM. Prevalence of cerebral amyloid angiopathy: a systematic review and meta-analysis. Alzheimers Dement. 2022;18(1):10–28. Article Google Scholar Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nat Rev Neurol. 2020;16(1):30–42. Article CAS Google Scholar Thal DR, Ghebremedhin E, Rüb U, Yamaguchi H, Del Tredici K, Braak H.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with H.
Contact H., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack